Elsevier

Kidney International Reports

Volume 1, Issue 3, September 2016, Pages 177-188
Kidney International Reports

Meeting Report
ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy

https://doi.org/10.1016/j.ekir.2016.07.007Get rights and content
Under a Creative Commons license
open access

Diabetic nephropathy (DN) is the major reason for end-stage renal disease in the Western world. Patients with DN developed more severe cardiovascular complications with worse prognosis. In spite of tight blood pressure and glucose control through applying angiotensin Ⅱ receptor antagonism, angiotensin receptor inhibitors, and even direct renin inhibitors, the progression and development of DN has continued to accelerate. Nuclear receptors are, with few exceptions, ligand-depended transcription factors, some of which modulate genes involved in the transport and metabolism of carbohydrates or lipids, and in the modulation of inflammation. Considering the diverse biological functions of nuclear receptors, efforts have been made to explore their contributions to the pathogenesis of DN and their potential in therapeutic strategies. This review is mainly focused on the association between various nuclear receptors and the pathogenesis of DN, the potential beneficial effects of targeting these receptors for treating and preventing the progress of DN, and the important role that nuclear receptors may play in future therapeutic strategies for DN.

Keywords

diabetic nephropathy
ESRD

Cited by (0)

4

These authors contributed equally to this work.